440 related articles for article (PubMed ID: 27641154)
1. Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.
Bertholee D; Maring JG; van Kuilenburg AB
Clin Pharmacokinet; 2017 Apr; 56(4):317-337. PubMed ID: 27641154
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
Bosch TM
Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
Bosch TM; Meijerman I; Beijnen JH; Schellens JH
Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and Pharmacogenetic Markers of Irinotecan Toxicity.
Hahn RZ; Antunes MV; Verza SG; Perassolo MS; Suyenaga ES; Schwartsmann G; Linden R
Curr Med Chem; 2019; 26(12):2085-2107. PubMed ID: 29932028
[TBL] [Abstract][Full Text] [Related]
5. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
van Schaik RH
Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627
[TBL] [Abstract][Full Text] [Related]
6. Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
Deeken JF; Figg WD; Bates SE; Sparreboom A
Anticancer Drugs; 2007 Feb; 18(2):111-26. PubMed ID: 17159598
[TBL] [Abstract][Full Text] [Related]
7. Cancer pharmacogenomics: achievements in basic research.
Nakajima M; Yokoi T
Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595
[TBL] [Abstract][Full Text] [Related]
8. Genetic determinants of cancer drug efficacy and toxicity: practical considerations and perspectives.
Candelaria M; Taja-Chayeb L; Arce-Salinas C; Vidal-Millan S; Serrano-Olvera A; Dueñas-Gonzalez A
Anticancer Drugs; 2005 Oct; 16(9):923-33. PubMed ID: 16162969
[TBL] [Abstract][Full Text] [Related]
9. TPMT, UGT1A1 and DPYD: genotyping to ensure safer cancer therapy?
Maitland ML; Vasisht K; Ratain MJ
Trends Pharmacol Sci; 2006 Aug; 27(8):432-7. PubMed ID: 16815558
[TBL] [Abstract][Full Text] [Related]
10. Cancer pharmacogenomics: international trends.
Yamayoshi Y; Iida E; Tanigawara Y
Int J Clin Oncol; 2005 Feb; 10(1):5-13. PubMed ID: 15729594
[TBL] [Abstract][Full Text] [Related]
11. Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review.
Stingl JC; Bartels H; Viviani R; Lehmann ML; Brockmöller J
Pharmacol Ther; 2014 Jan; 141(1):92-116. PubMed ID: 24076267
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.
Bosch TM; Doodeman VD; Smits PH; Meijerman I; Schellens JH; Beijnen JH
Mol Diagn Ther; 2006; 10(3):175-85. PubMed ID: 16771603
[TBL] [Abstract][Full Text] [Related]
13. [SNPs associated with adverse effects].
Isomura M; Miki Y
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1908-13. PubMed ID: 16282725
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics in cancer treatment.
Nagasubramanian R; Innocenti F; Ratain MJ
Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of tipifarnib (R115777) transport and metabolism in cancer patients.
Sparreboom A; Marsh S; Mathijssen RH; Verweij J; McLeod HL
Invest New Drugs; 2004 Aug; 22(3):285-9. PubMed ID: 15122075
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacogenetics and potential application in personalized medicine.
Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
[TBL] [Abstract][Full Text] [Related]
17. Genotyping and phenotyping cytochrome P450: perspectives for cancer treatment.
Mathijssen RH; van Schaik RH
Eur J Cancer; 2006 Jan; 42(2):141-8. PubMed ID: 16325399
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacogenetics of anticancer drugs].
de Chaisemartin L; Loriot MA
Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
[TBL] [Abstract][Full Text] [Related]
19. Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer.
Sauna ZE; Kimchi-Sarfaty C; Ambudkar SV; Gottesman MM
Cancer Res; 2007 Oct; 67(20):9609-12. PubMed ID: 17942888
[TBL] [Abstract][Full Text] [Related]
20. PharmFrag: An Easy and Fast Multiplex Pharmacogenetics Assay to Simultaneously Analyze 9 Genetic Polymorphisms Involved in Response Variability of Anticancer Drugs.
Bouvet R; Verdier MC; El Baroudi Y; Galibert MD; David V; Schutz S; Tron C
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
